Lung Kee Group Holdings (HKSE:00255) Altman Z2-Score: 10.76 (As of Aug. 11, 2026) — 14% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00255 Lung Kee Group Holdings Ltd HKSE:00255
67 GF Score
Price HK$1.50
GF Value HK$1.24
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Lung Kee Group Holdings Altman Z2-Score?

Lung Kee Group Holdings HKSE:00255 67 Altman Z2-Score is 10.76 as of Aug. 11, 2026, which is 14% above its 10-year median of 9.40. GuruFocus rates HKSE:00255 with a GF Score™ of 67/100 and a GF Value™ of HK$1.24 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 2,975 Industrial Products companies, Lung Kee Group Holdings ranks better than 91.56% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Good Sign:

Lung Kee Group Holdings has a Altman Z2-Score of 10.76, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Lung Kee Group Holdings's Altman Z2-Score or its related term are showing as below:

HKSE:00255' s Altman Z2-Score Range Over the Past 10 Years
Min: 8.55   Med: 9.4   Max: 11.53
Current: 10.76

During the past 13 years, Lung Kee Group Holdings's highest Altman Z2-Score was 11.53. The lowest was 8.55. And the median was 9.40.


Lung Kee Group Holdings  (HKSE:00255) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Lung Kee Group Holdings Altman Z2-Score Related Terms


Lung Kee Group Holdings Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Lung Kee Group Holdings's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lung Kee Group Holdings Altman Z2-Score Chart

Lung Kee Group Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.09 11.53 10.69 10.68 10.76

Lung Kee Group Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.69 0.00 10.68 0.00 10.76

HKSE:00255 vs CRS, ATI, MLI: Altman Z2-Score Comparison

For the Metal Fabrication subindustry, Lung Kee Group Holdings's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lung Kee Group Holdings Altman Z2-Score vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Lung Kee Group Holdings's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Lung Kee Group Holdings's Altman Z2-Score falls into.


HKSE:00255
67GF Score
Lung Kee Group Holdings Ltd HKSE:00255
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lung Kee Group Holdings Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Lung Kee Group Holdings's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.5076+3.26*0.4456+6.72*-0.0181+1.05*5.8104
=10.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2025:
Total Assets was HK$1,818 Mil.
Total Current Assets was HK$1,102 Mil.
Total Current Liabilities was HK$180 Mil.
Retained Earnings was HK$810 Mil.
Pre-Tax Income was HK$-33 Mil.
Interest Expense was HK$-0 Mil.
Total Liabilities was HK$267 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(1102.424 - 179.705)/1817.874
=0.5076

X2=Retained Earnings/Total Assets
=809.977/1817.874
=0.4456

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-33.147 - -0.309)/1817.874
=-0.0181

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(1550.946 - 0)/266.928
=5.8104

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Lung Kee Group Holdings has a Altman Z2-Score of 10.76 indicating it is in Safe Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 10.76 mean?
Lung Kee Group Holdings (HKSE:00255) has a Altman Z2-Score of 10.76 as of Aug. 11, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Lung Kee Group Holdings and its competitors. This is 14% above median its historical median of 9.40. Over the past decade, Lung Kee Group Holdings' Altman Z2-Score has ranged from 8.55 to 11.53. According to the industry distribution chart, Lung Kee Group Holdings ranks #251 out of 2975 companies in the Industrial Products industry, placing it in the top 8.4%.
Is Lung Kee Group Holdings' Altman Z2-Score too high?
Lung Kee Group Holdings' current Altman Z2-Score of 10.76 is 14% above median its 10-year median of 9.40. Over the past 10 years, this metric has ranged from a low of 8.55 to a high of 11.53. The Industrial Products industry median Altman Z2-Score is 4.23. Lung Kee Group Holdings' value of 10.76 is 154.4% above this industry median. Based on the distribution chart, Lung Kee Group Holdings ranks #251 out of 2975 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Lung Kee Group Holdings has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lung Kee Group Holdings' Altman Z2-Score compare to CRS and ATI?
According to the Industrial Products industry distribution chart, Lung Kee Group Holdings ranks #251 out of 2975 companies for Altman Z2-Score. This places Lung Kee Group Holdings in the top 8% of its industry — outperforming the majority of peers. The industry median Altman Z2-Score is 4.23. Lung Kee Group Holdings' value of 10.76 is 154.4% above this benchmark. Historically, Lung Kee Group Holdings' own Altman Z2-Score has ranged from 8.55 to 11.53 over the past decade. While the company's 10-year median is 9.40 vs. the industry median of 4.23, Lung Kee Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for an Industrial Products company?
The median Altman Z2-Score among Industrial Products companies is 4.23, based on 2,975 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lung Kee Group Holdings's current Altman Z2-Score of 10.76 is 154.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Lung Kee Group Holdings and its competitors. For the Industrial Products industry, the median Altman Z2-Score is 4.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lung Kee Group Holdings's current Altman Z2-Score is 10.76, which is 14% above median its own 10-year median of 9.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lung Kee Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Lung Kee Group Holdings (HKSE:00255) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$1.24, compared to a current price of HK$1.50 — trading 20.6% above its estimated fair value. The current Altman Z2-Score is 10.76, which is 14% above median its 10-year median of 9.40 and 154.4% above the Industrial Products industry median of 4.23. Lung Kee Group Holdings' overall GF Score™ is 67/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Lung Kee Group Holdings (HKSE:00255), the current Altman Z2-Score is 10.76 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lung Kee Group Holdings (HKSE:00255) Overvalued in 2026?

Based on GuruFocus' analysis, Lung Kee Group Holdings stock appears to be overvalued. The current stock price of HK$1.50 is trading 20.6% above its estimated GF Value™ of HK$1.24. GuruFocus considers Lung Kee Group Holdings to be Modestly Overvalued.

Key valuation signals for HKSE:00255:

  • Altman Z2-Score: 10.76 (14% above median its 10-year median of 9.40)
  • GF Value™: HK$1.24 vs. price of HK$1.50 (20.6% above fair value)
  • GF Score™: 67/100 with 1 warning sign
  • Industry Position: 154.4% above the Industrial Products median (#251 of 2975)

No single metric tells the full story. See the HKSE:00255 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lung Kee Group Holdings Business Description

Address No. 1 On Kwan Street, Unit A, 15th Floor, Kings Wing Plaza 2, Sha Tin, New Territories, Hong Kong, HKG
Lung Kee Group Holdings Ltd is an investment holding company that provides corporate management services. Along with its subsidiaries, it is engaged in the manufacturing and marketing of mould bases and related products. Its product offerings include standard and custom-made mould base, mould components, tool and steel products such as plastic and steel mould, hot and cold work steel, precision plates, standard mould inserts, and other materials. The company generates a majority of its revenue from the People's Republic of China and the rest from other markets like Asia, Europe, and America.
67GF Score

Get the complete analysis for HKSE:00255

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.50
Price
HK$1.24
GF Value